Literature DB >> 25480889

Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.

Guang Bai1, Iris Cheung2, Hennady P Shulha3, Joana E Coelho4, Ping Li4, Xianjun Dong3, Mira Jakovcevski2, Yumei Wang4, Anastasia Grigorenko2, Yan Jiang5, Andrew Hoss4, Krupal Patel1, Ming Zheng1, Evgeny Rogaev2, Richard H Myers6, Zhiping Weng3, Schahram Akbarian7, Jiang-Fan Chen8.   

Abstract

To investigate epigenetic contributions to Huntington's disease (HD) pathogenesis, we carried out genome-wide mapping of the transcriptional mark, trimethyl-histone H3-lysine 4 (H3K4me3) in neuronal nuclei extracted from prefrontal cortex of HD cases and controls using chromatin immunoprecipitation followed by deep-sequencing. Neuron-specific mapping of the genome-wide distribution of H3K4me3 revealed 136 differentially enriched loci associated with genes implicated in neuronal development and neurodegeneration, including GPR3, TMEM106B, PDIA6 and the Notch signaling genes hairy and enhancer of split 4 (HES4) and JAGGED2, supporting the view that the neuronal epigenome is affected in HD. Importantly, loss of H3K4me3 at CpG-rich sequences on the HES4 promoter was associated with excessive DNA methylation, reduced binding of nuclear proteins to the methylated region and altered expression of HES4 and HES4 targeted genes MASH1 and P21 involved in striatal development. Moreover, hypermethylation of HES4 promoter sequences was strikingly correlated with measures of striatal degeneration and age-of-onset in a cohort of 25 HD brains (r = 0.56, P = 0.006). Lastly, shRNA knockdown of HES4 in human neuroblastoma cells altered MASH1 and P21 mRNA expression and markedly increased mutated HTT-induced aggregates and cell death. These findings, taken together, suggest that epigenetic dysregulation of HES4 could play a critical role in modifying HD disease pathogenesis and severity.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480889      PMCID: PMC4321450          DOI: 10.1093/hmg/ddu561

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  84 in total

1.  Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase.

Authors:  Xiao-Jian Sun; Ju Wei; Xin-Yan Wu; Ming Hu; Lan Wang; Hai-Hong Wang; Qing-Hua Zhang; Sai-Juan Chen; Qiu-Hua Huang; Zhu Chen
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

Review 2.  Brain networks in Huntington disease.

Authors:  David Eidelberg; D James Surmeier
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

3.  Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.

Authors:  Jim P Dompierre; Juliette D Godin; Bénédicte C Charrin; Fabrice P Cordelières; Stephen J King; Sandrine Humbert; Frédéric Saudou
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

Review 4.  Like a rolling histone: epigenetic regulation of neural stem cells and brain development by factors controlling histone acetylation and methylation.

Authors:  Tobias Lilja; Nina Heldring; Ola Hermanson
Journal:  Biochim Biophys Acta       Date:  2012-08-16

5.  TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease.

Authors:  Nicola J Rutherford; Minerva M Carrasquillo; Ma Li; Gina Bisceglio; Joshua Menke; Keith A Josephs; Joseph E Parisi; Ronald C Petersen; Neill R Graff-Radford; Steven G Younkin; Dennis W Dickson; Rosa Rademakers
Journal:  Neurology       Date:  2012-08-01       Impact factor: 9.910

6.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

Review 7.  Epigenetic regulation in human brain-focus on histone lysine methylation.

Authors:  Schahram Akbarian; Hsien-Sung Huang
Journal:  Biol Psychiatry       Date:  2008-09-24       Impact factor: 13.382

8.  Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.

Authors:  L Djoussé; B Knowlton; M Hayden; E W Almqvist; R Brinkman; C Ross; R Margolis; A Rosenblatt; A Durr; C Dode; P J Morrison; A Novelletto; M Frontali; R J A Trent; E McCusker; E Gómez-Tortosa; D Mayo; R Jones; A Zanko; M Nance; R Abramson; O Suchowersky; J Paulsen; M Harrison; Q Yang; L A Cupples; J F Gusella; M E MacDonald; R H Myers
Journal:  Am J Med Genet A       Date:  2003-06-15       Impact factor: 2.802

9.  Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2.

Authors:  Diego Pasini; Klaus H Hansen; Jesper Christensen; Karl Agger; Paul A C Cloos; Kristian Helin
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

10.  Mash1 regulates neurogenesis in the ventral telencephalon.

Authors:  S Casarosa; C Fode; F Guillemot
Journal:  Development       Date:  1999-02       Impact factor: 6.868

View more
  29 in total

1.  Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory.

Authors:  Mira Jakovcevski; Hongyu Ruan; Erica Y Shen; Aslihan Dincer; Behnam Javidfar; Qi Ma; Cyril J Peter; Iris Cheung; Amanda C Mitchell; Yan Jiang; Cong L Lin; Venu Pothula; A Francis Stewart; Patricia Ernst; Wei-Dong Yao; Schahram Akbarian
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

Review 2.  Epigenetic Regulation in Neurodegenerative Diseases.

Authors:  Amit Berson; Raffaella Nativio; Shelley L Berger; Nancy M Bonini
Journal:  Trends Neurosci       Date:  2018-06-07       Impact factor: 13.837

3.  Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice.

Authors: 
Journal:  Nat Neurosci       Date:  2017-03-20       Impact factor: 24.884

4.  Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease.

Authors:  Wan Song; Nóra Zsindely; Anikó Faragó; J Lawrence Marsh; László Bodai
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

5.  Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia.

Authors:  Michael Zech; Sylvia Boesch; Esther M Maier; Ingo Borggraefe; Katharina Vill; Franco Laccone; Veronika Pilshofer; Andres Ceballos-Baumann; Bader Alhaddad; Riccardo Berutti; Werner Poewe; Tobias B Haack; Bernhard Haslinger; Tim M Strom; Juliane Winkelmann
Journal:  Am J Hum Genet       Date:  2016-11-10       Impact factor: 11.025

6.  Self-injurious behaviours in rhesus macaques: Potential glial mechanisms.

Authors:  J Ramsey; E C Martin; O M Purcell; K M Lee; A G MacLean
Journal:  J Intellect Disabil Res       Date:  2018-12

Review 7.  Epigenetics and therapeutic targets mediating neuroprotection.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Brain Res       Date:  2015-07-30       Impact factor: 3.252

Review 8.  DNA methylation in Huntington's disease: Implications for transgenerational effects.

Authors:  Elizabeth A Thomas
Journal:  Neurosci Lett       Date:  2015-11-11       Impact factor: 3.046

Review 9.  Understanding the genetic liability to schizophrenia through the neuroepigenome.

Authors:  John F Fullard; Tobias B Halene; Claudia Giambartolomei; Vahram Haroutunian; Schahram Akbarian; Panos Roussos
Journal:  Schizophr Res       Date:  2016-01-27       Impact factor: 4.939

Review 10.  Histone Methylation Regulation in Neurodegenerative Disorders.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.